Skip to main content
Ajooni Biotech Limited logo

Ajooni Biotech Limited — Investor Relations & Filings

Ticker · AJOONI ISIN · INE820Y01021 LEI · 335800OAKJWKHF49O339 National Stock Exchange of India Manufacturing
Open in API
Filings indexed 562 across all filing types
Latest filing 2022-08-26 AGM Information
Country IN India
Listing National Stock Exchange of India AJOONI

About Ajooni Biotech Limited

https://www.ajoonibiotech.com

Ajooni Biotech Limited specializes in the production and distribution of animal healthcare solutions and nutritional supplements. The company focuses on the livestock sector, offering a comprehensive range of products including compounded cattle feed, mineral mixtures, and specialized supplements formulated to enhance milk productivity and overall animal health. Its portfolio features calcium supplements, liver tonics, and digestive aids designed to meet the specific nutritional needs of dairy animals. The company utilizes research-driven formulations and quality-controlled manufacturing processes to provide effective solutions for livestock management. By prioritizing animal welfare and productivity, it supports the operational efficiency of dairy farming through scientifically developed nutritional interventions.

Recent filings

Filing Released Lang Actions
Newspaper Advertisements
AGM Information Classification · 95% confidence The document is a notice regarding the 12th Annual General Meeting (AGM) of Ajooni Biotech Limited. It includes details about the AGM date, remote e-voting instructions, book closure dates, and publication of the notice in newspapers as per SEBI regulations. The document does not contain the actual annual report or financial statements but rather announces the AGM and related voting procedures. It also references the availability of the annual report on the company's website and stock exchange websites, indicating this document is an announcement rather than the report itself. The length is about 15,000 characters, but the content is focused on the AGM notice and voting information, consistent with an AGM Information filing rather than an Annual Report or other financial report. Therefore, the appropriate classification is AGM Information (AGM-R).
2022-08-26 English
Book Closure
AGM Information Classification · 95% confidence The document is a short notice from Ajooni Biotech addressed to the National Stock Exchange of India regarding the book closure dates for the purpose of the 12th Annual General Meeting (AGM). It references Regulation 42 of SEBI (Listing Obligations and Disclosure Requirements) and specifies the dates for closing the register of members to determine eligibility for voting at the AGM. The document does not contain any financial data, detailed report, or results but is an announcement related to the AGM process. Given the short length (1338 characters) and the nature of the content (intimation of book closure for AGM), this fits the category of AGM Information (AGM-R) rather than the AGM report itself or any other filing type.
2022-08-25 English
Outcome of Board Meeting
Board/Management Information Classification · 95% confidence The document is a detailed announcement of the outcome of a Board Meeting held on August 25, 2022, by SNI Biotech Limited. It includes multiple board decisions such as appointments and re-appointments of directors, remuneration revisions, share subdivision proposals, approval of draft director's report for the fiscal year 2021-22, and scheduling of the 12th Annual General Meeting (AGM). The document also contains brief profiles of the appointed/re-appointed directors. The content focuses on board and management changes and related corporate governance matters. There is no presentation of financial statements or detailed financial performance data, so it is not an Annual Report or Interim Report. It is not a proxy solicitation or voting results announcement. The primary focus is on board and management information, including appointments and remuneration changes, which fits the category of Board/Management Information (MANG). The document length (about 15,000 characters) and detailed content support this classification with high confidence.
2022-08-25 English
General updates
Capital/Financing Update Classification · 95% confidence The document is a short announcement from Ajooni Biotech Limited addressed to the National Stock Exchange of India. It informs about the purchase of land for expansion of the product range and upcoming commercial production. There are no financial statements, regulatory filings, or detailed reports included. The content is an update on company activities related to capital assets and expansion, which fits the category of Capital/Financing Update (CAP). The document length is short (1144 characters), and it is not a report or a notice of voting, dividend, or management change. Therefore, the best classification is CAP with high confidence.
2022-08-18 English
Board Meeting — Alteration of form/nature/rights of securities/Other business matters
Board/Management Information Classification · 95% confidence The document is a formal notice addressed to the National Stock Exchange of India regarding an upcoming Board Meeting scheduled for August 25, 2022. The agenda includes discussion on appointment/change of a Whole time Director, share subdivision, amendment in capital clause, approval of Director's Report for FY 2021-22, and arrangements for the 12th Annual General Meeting. The document is an announcement of a Board Meeting and related corporate actions, not the actual report or financial statements. It fits the category of Board/Management Information (MANG) as it involves board meeting notification and management decisions.
2022-08-06 English
Outcome of Board Meeting
Interim / Quarterly Report Classification · 95% confidence The document is a communication from Ajooni Biotech Limited to the National Stock Exchange of India dated August 5, 2022. It announces the approval and outcome of the Board Meeting held on the same day, specifically mentioning the approval of the Un-Audited Financial Results for the quarter ended June 30, 2022, and the Limited Review Report from the auditor for that quarter. The document includes detailed financial data for the quarter, such as income, expenses, profit/loss, and assets and liabilities. The presence of actual financial statements and substantive financial data for a quarter indicates this is a quarterly financial report. The document is not merely an announcement of a report or a certification but contains the financial results themselves. Therefore, it fits the definition of an Interim / Quarterly Report (IR). Q1 2023
2022-08-05 English

Browse filings by year

9 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.